Comparison of Early-onset Efficacy of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies for Patients with Migraine in Real-world Clinical Practice: Study Protocol for an Exploratory Clinical Trial

Three anti-calcitonin gene-related peptide monoclonal antibodies (CGRP-mAbs) are available in Japan: galcanezumab, fremanezumab, and erenumab. Early-onset efficacy has been demonstrated for each CGRP-mAb in comparison with placebo, but differences among the drugs are unclear. Only galcanezumab requi...

Full description

Bibliographic Details
Published in:	Neurologia Medico-Chirurgica
Main Authors:	Takafumi TANEI, Satoshi MAESAWA, Yusuke NISHIMURA, Tomotaka ISHIZAKI, Yoshitaka NAGASHIMA, Miki HASHIDA, Shun YAMAMOTO, Masahiko ANDO, Yachiyo KUWATSUKA, Atsushi HASHIZUME, Toshihiko WAKABAYASHI, Ryuta SAITO
Format:	Article
Language:	English
Published:	The Japan Neurosurgical Society 2025-02-01
Subjects:	early-onset efficacy anti-calcitonin gene-related peptide monoclonal antibody cgrp migraine discontinuation
Online Access:	https://www.jstage.jst.go.jp/article/nmc/65/2/65_2024-0201/_pdf/-char/en

Similar Items

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization
by: Takafumi Tanei, et al.
Published: (2024-11-01)

Efficacy of the latest new stimulation patterns of spinal cord stimulation for intractable neuropathic pain compared to conventional stimulation: study protocol for a clinical trial
by: Takafumi Tanei, et al.
Published: (2023-09-01)

Differential target multiplexed spinal cord stimulation using a paddle-type lead placed at the appropriate site for neuropathic pain after spinal cord injury in patients with past spinal surgical histories: study protocol for an exploratory clinical trial
by: Takafumi Tanei, et al.
Published: (2023-06-01)

Effects of formononetin on the expression of orexin and calcitonin gene-related peptide genes in a stress model rats
by: Elaheh Basirat, et al.
Published: (2024-12-01)

Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception—Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab
by: Nicola Benedicter, et al.
Published: (2024-03-01)

Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study
by: Nik Krajnc, et al.
Published: (2024-06-01)

Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice
by: Takafumi Tanei, et al.
Published: (2025-04-01)

Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions
by: Yee Jung Kim, et al.
Published: (2021-12-01)

A brief discussion on the role of calcitonin gene-related peptide in the efficacy of rehabilitation medicine
by: Guan Zhencheng, et al.
Published: (2025-06-01)

Protective Role of α-Calcitonin Gene-Related Peptide in Cardiovascular Diseases
by: Ambrish Kumar, et al.
Published: (2019-07-01)

Use of rimegepant as an alternative to triptans in migraine treatment
by: Aleksandra Jaroń, et al.
Published: (2024-08-01)

Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
by: Todd J. Schwedt, et al.
Published: (2023-11-01)

Health Technology Assessment: Evaluation of 8 CGRP-Targeted Therapy Drugs for the Treatment of Migraine
by: Li M, et al.
Published: (2025-02-01)

Permanent visual impairment following a Behçet’s disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report
by: Fawad A. Khan, et al.
Published: (2025-09-01)

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?
by: Theodoros Mavridis, et al.
Published: (2021-07-01)

Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation
by: Michael Lowe, et al.
Published: (2022-07-01)

Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system
by: Aida Maddahi, et al.
Published: (2024-11-01)

Mode and site of action of therapies targeting CGRP signaling
by: Alejandro Labastida-Ramírez, et al.
Published: (2023-09-01)

Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01)

Mice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing
by: Jessika Appelt, et al.
Published: (2021-09-01)

Gut microbiota modulates visceral sensitivity through calcitonin gene-related peptide (CGRP) production
by: Julien Pujo, et al.
Published: (2023-12-01)

CGRP: New Focus in Migraine
by: Necdet Karlı, et al.
Published: (2022-03-01)

Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)
by: Davor Jančuljak, et al.
Published: (2024-01-01)

Current concept of the pathophysiology of migraine and new targets for its therapy
by: G. R. Tabeeva, et al.
Published: (2020-08-01)

Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-review
by: Tulsi Shah, et al.
Published: (2023-03-01)

Alpha‐calcitonin gene‐related peptide prevents pressure‐overload induced heart failure: role of apoptosis and oxidative stress
by: Ambrish Kumar, et al.
Published: (2019-11-01)

Calcitonin values in pseudohypoparathyroidism
by: Marković Bojan, et al.
Published: (2023-01-01)

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
by: Marcelo Bragança dos Reis Oliveira, et al.
Published: (2018-10-01)

Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study
by: Ji-Hoon Na, et al.
Published: (2025-05-01)

Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons
by: Sofia Lyng Wæver, et al.
Published: (2025-01-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
by: Manuela Rizzi, et al.
Published: (2022-09-01)

A Novel Peptoid Hybrid of Alpha-Calcitonin Gene-Related Peptide (α-CGRP) Ameliorates Cardiac Remodeling in Pressure Overload-Induced Heart Failure
by: Sarah Deloach, et al.
Published: (2025-10-01)

Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopaedic infections
by: C Garzoni, et al.
Published: (2010-11-01)

Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers
by: Mamoru Shibata, et al.
Published: (2024-01-01)

The endogenous neuropeptide calcitonin gene-related peptide after spontaneous subarachnoid hemorrhage–A potential psychoactive prognostic serum biomarker of pain-associated neuropsychological symptoms
by: Elisabeth Bründl, et al.
Published: (2022-07-01)

Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
by: Hadeel M. Hameed, et al.
Published: (2025-01-01)

Thalamic neural activity and epileptic network analysis using stereoelectroencephalography: a prospective study protocol
by: Takahiro Suzuki, et al.
Published: (2025-06-01)

A calcitonin-producing pancreatic neuroendocrine neoplasm treated with distal pancreatectomy a lengthy time after a left trisectionectomy for liver metastases: a case report
by: Ryusei Yamamoto, et al.
Published: (2022-12-01)